Health Hearing: The Fiscal Year 2027 Department of Health and Human Services Budget

This transcript captures a House Committee on Energy and Commerce hearing held on April 22, 2026, focused on the fiscal year 2027 budget for the Department of Health and Human Services (HHS). Secretary Robert F. Kennedy Jr. testified regarding the administration's health priorities, including investments in rural health, prevention, transparency in healthcare pricing, combating fraud and abuse, and accelerating drug development, particularly for rare diseases. The hearing featured extensive discussion on budget allocations, program eliminations (such as CDC's Safe Motherhood program and Title 10 family planning), and policy changes affecting Medicaid, Medicare Advantage, and public health programs. Members debated the impact of budget cuts, fraud detection efforts, and regulatory reforms, with particular attention to vaccine policies, healthcare affordability, and research funding. Secretary Kennedy highlighted a $50 billion investment in rural health over five years and efforts to reduce drug prices through negotiated agreements. Several members raised concerns about program eliminations, funding delays, and the administration's approach to vaccine safety and public health infrastructure. The hearing also addressed enforcement of price transparency rules, fraud prevention initiatives, and efforts to support domestic pharmaceutical manufacturing. Multiple votes or motions were not recorded in the transcript, but numerous commitments to collaborate on legislation and oversight were expressed.